COVID-19 serology surveillance strategy

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Up-to-date Information

Up-to-Date Info: To find the latest CDC information on this topic go to: https://www.cdc.gov/coronavirus/2019-ncov/index.html

COVID-19 serology surveillance strategy

May 17, 2020
By National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. ...
Series: Coronavirus Disease 2020 (COVID-19)

[PDF-86.77 KB]

English

Details Supporting Files Related Documents You May Also Like

Details:

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. ; United States. Department of Homeland Security. Cybersecurity and Infrastructure Security Agency‏.

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. ; United States. Department of Homeland Security. Cybersecurity and Infrastructure Security Agency‏. Less -
Description:

CDC is working with state, local, territorial, academic, and commercial partners to better understand COVID-19 in the United States. CDC has an overarching strategy for learning more about how many people have been infected with SARS-CoV-2, the virus that causes COVID-19, and how it is spreading through the U.S. population. This strategy includes using serology testing for surveillance to better understand how many infections with SARS-CoV-2 have occurred:

• At different points in time,

• In different locations, and

• Within different populations in the United States.

Serology tests look for antibodies in blood. If antibodies are found, that means there has been a previous infection. Antibodies are proteins that can fight off infections. Investigations using serology testing are called seroprevalence surveys. CDC is collaborating with public health and private partners on a variety of seroprevalence surveys of different sizes, locations, populations studied, and purposes. The seroprevalence surveys CDC is conducting include large-scale geographic surveys, community level surveys, and smaller-scale surveys focusing on specific populations in order to learn more about COVID-19.
Content Notes:

Objectives of Surveillance of U.S. Serology Testing -- Serology testing surveillance provides important information -- Serology tests look for antibodies.
Subjects:

[+]

Coronavirus Infections/diagnosis COVID-19 Diagnostic Tests, Routine Serologic Tests
Series:

Coronavirus Disease 2020 (COVID-19)
Document Type:

Webpage
Collection(s):

Stephen B. Thacker CDC Library collection
Main Document Checksum:

[+]

urn:sha256:6f51a97e3c7c7836f7fc9819b8022e503a68bedaacbb84396c675940f2174eda
Download URL:

https://stacks.cdc.gov/view/cdc/88069/cdc_88069_DS1.pdf
File Type:

index.html

htm

More +